Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hologic Inc (HOLX): Icahn Unloads Shares, Gives Up Board Seats

Billionaire activist Carl Icahn of Icahn Capital has unloaded over 2.82 million shares of Hologic Inc. (NASDAQ:HOLX) in a series of transactions over the past two weeks according to a 13D filing issued with the SEC this morning. Icahn Capital retains 25.33 million shares of Hologic, down from the 28.15 million shares that it held at the end of 2015. Item 4 of the filing also shows that two employees of Icahn have resigned from their positions as Directors of Hologic. Item 4 of the filing states:

On March 3, 2016, Jonathan Christodoro and Samuel Merksamer, employees of the Reporting Persons, resigned as directors of the Issuer. As a result of their resignations and the Reporting Persons’ decision not to replace them on the Board of Directors of the Issuer, the Standstill Period (as such term is defined in the Nomination and Standstill Agreement, dated as of December 8, 2013, among the Reporting Persons and the Issuer) has terminated.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
High River Limited Partnership 5,066,119 0 5,066,119 0 5,066,119 1.78%
Hopper Investments 0 5,066,119 0 5,066,119 5,066,119 1.78%
Barberry Corp 0 5,066,119 0 5,066,119 5,066,119 1.78%
Icahn Partners Master Fund 8,440,520 0 8,440,520 0 8,440,520 2.97%
Icahn Offshore 0 8,440,520 0 8,440,520 8,440,520 2.97%
Icahn Partners 11,823,963 0 11,823,963 0 11,823,963 4.17%
Icahn Onshore 0 11,823,963 0 11,823,963 11,823,963 4.17%
Icahn Capital 0 20,264,483 0 20,264,483 20,264,483 7.14%
IPH GP 0 20,264,483 0 20,264,483 20,264,483 7.14%
Icahn Enterprises Holdings 0 20,264,483 0 20,264,483 20,264,483 7.14%
Icahn Enterprises G.P. Inc 0 20,264,483 0 20,264,483 20,264,483 7.14%
Beckton Corp 0 20,264,483 0 20,264,483 20,264,483 7.14%
Carl C. Icahn 0 25,330,602 0 25,330,602 25,330,602 8.92%
Carl Icahn
Carl Icahn
Icahn Capital LP

Page 1 of 17 SEC Filing

Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Hologic, Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
(CUSIP Number)
Jesse Lynn, Esq.
Icahn Capital LP
767 Fifth Avenue, 47th Floor
New York, New York 10153
(212) 702-4300
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
March 3, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /.
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d‑7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Hologic Inc (NASDAQ:HOLX)
Trade (NASDAQ:HOLX) Now!